Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Influenza, Human

• Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza
• Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease
• Xofluza-Wearables Feasibility-Study
• Influenza Viral Challenge Study of CC-42344 in Healthy Participants
• HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
• A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza
• Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)
• Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses
• Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China
• Pharmacokinetic Characteristics, Safety, and Tolerability in Subjects With Mild or Moderate Liver Insufficiency and Healthy Subjects
• A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults With Uncomplicated Influenza
• ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza
• A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections
• The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
• Phase 2 Study of the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
• Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model
• Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile
• Study to Assess the Efficacy and Safety of GP681 Tablets in the Treatment of Acute Uncomplicated Influenza Virus Infection
• Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children
• Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
• Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection
• Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection
• Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections
• INNA-051 Influenza Challenge Study
• CC-42344 Phase 1 Safety and PK Study in Healthy Participants
• Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
• Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.
• Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza
• Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza
• Effect of One-week vs Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
• Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
• Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting
• A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pre
• A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections
• Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
• Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
• Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
• First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults
• Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections
• An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
• A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older
• Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
• A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
• Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
• To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection
• A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A
• Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.
• Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
• Influenza Vaccine in Lung Transplant Patients - Antibody
• Influenza Vaccine in Lung Transplant Patients - T Cells
• Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
• Influenza Vaccine in Lung Transplant Patients - Seroprotection
• Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
• An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
• Universal Anti-Viral Vaccine for Healthy Elderly Adults
• A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers
• Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
• COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)
• DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)
• Different Regimens in Influenza Postexposure Chemoprophylaxis in Children
• Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
• Clinical Study of Reduning Injection for the Treatment of Influenza in Children
• Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
• Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
• Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
• Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle
• B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
• Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
• Study of VIR-2482 in Healthy Volunteers
• Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A
• Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
• Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
• Flublok or Fluzone With Advax-CpG55.2 or AF03
• Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza
• Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza
• Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia
• Prophylactic Treatment With Oseltamivir
• Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
• Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI
• A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever
• Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community
• Severe Influenza Trial of ARbidol
• A Phase 2, Double-blind Study to Evaluate Immunogenicity and Safety of Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult Volunteers
• Oseltamivir Versus Paracetamol for Influenza-like Illness During the Influenza Season
• Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine
• 2017 A/H7N9 IIV Revaccination
• Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza
• Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms
• Influenza Vaccine Responses
• 2013/2017 H7N9 Prime-Boost Interval
• A Study to Investigate the Efficacy, Safety of CT-P27 in Acute Uncomplicated Influenza A Infection
• H5N1 With or Without Topical Aldara in Healthy Adults
• Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections
• XC8 in the Treatment of Patients With Acute Respiratory Viral Infection
• Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza
• A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
• Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
• Influenza Management With Polyherbal Formulation
• A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
• Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4
• Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly
• Improved Novel VaccIne CombinaTion InflUenza Study
• The Immune Response to Influenza Vaccinations in Elderly Individuals
• Flufenamic Acid for Hospitalised Influenza Infection
• Study Examining PrEP-001 in Healthy Subjects
• Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.
• Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
• Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults
• Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine
• Study to Evaluate the Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support
• Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
• Study of VIS410 in Subjects With Uncomplicated Influenza A
• A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia
• Influenza Vaccine Feasibility Study in Children With Persistent Asthma
• Imiquimod and Influenza Vaccine for Immunocompromised Patients
• A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
• Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications
• Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza
• H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
• 2-week dc of MTX and Influenza Vaccination in RA
• A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872
• A Clinical Trial of KT07 Capsule in the U.S.A
• Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
• Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections
• Lingdancao Granules in the Treatment of Seasonal Influenza
• A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation
• Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold
• Efficacy and Safety of Irlanda-1-Association on the Treatment of Common Cold in Children
• Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.
• Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
• A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults
• Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
• ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir
• A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza
• A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study
• A Clinical Study of Treating Influenza With Liugan Shuangjie Heji
• A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza
• Efficacy & Safety of Nasal Influenza Immunisation in Children
• A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
• Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
• Influenza Challenge Study of VIS410 in Healthy Volunteers
• Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
• Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
• Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
• Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
• Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults
• Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
• A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection
• Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV
• Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients
• A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
• Banlangen Granules Anti-seasonal Influenza Study
• H7N9 Mix and Match With MF59 in Healthy Elderly Persons
• The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
• Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
• A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1
• Treatment of Severe Influenza A Infection
• Intradermal Influenza Vaccine in the Young
• Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
• A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
• Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
• Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.
• Statin Therapy in Acute Influenza
• A Study of VIS410 to Assess Safety and Pharmacokinetics
• A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
• Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316
• Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
• Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults
• Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects
• Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
• Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
• H7N9 Mix and Match With AS03 and MF59 in Healthy Adults
• H7N9 Mix and Match With MF59 in Healthy Adults
• Self-Administered Nasal Influenza Feasibility Study
• Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda
• The Benefit and Harm of Fever Suppression by Antipyretics in Influenza
• Immune Response To Intranasal Influenza Vaccination
• Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
• Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza
• Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
• Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections
• Testing the AVI-7100 Flu Drug in Healthy Volunteers
• Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza
• Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
• T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
• A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection
• Panama and El Salvador Children's Oseltamivir Study
• Efficacy and Safety of Influenza Vaccine During Sarcoidosis
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
• Study to Investigate the Efficacy and Safety of Apomivir®
• Evaluating Immune Response to Seasonal FluMist in Healthy Adults
• A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold
• Influenza Antiviral DAS-181-F04 in Healthy Adults
• Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season
• Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
• Safety Study of FluMist With and Without Ampligen
• H5N1 Vaccination With and Without AS03: Systems Biology Analysis
• A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus
• Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One
• Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells
• A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
• Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
• Intradermal Trivalent Influenza Vaccine With Imiquimod
• Safety of Inhaled Zanamivir in Pregnancy
• Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
• Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males
• Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
• Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome
• Safety Study of Single Administration Intravenous Treatment for Influenza
• A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers
• A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies
• H5N1 Mix and Match With AS03
• H5N1 Mix and Match With MF59
• Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
• Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
• Convalescent Plasma Treatment in Severe 2009 H1N1 Infection
• Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)
• A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers
• Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
• Effect of Oseltamivir on Cognitive Function in Subjects With Influenza
• Rapid Empiric Treatment With Oseltamivir Study (RETOS)
• Swine Flu (Influenza A H1N1) Follow on Vaccine Study
• A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
• Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
• Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza
• Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
• A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
• Relenza® Sentinel Site Monitoring Program in Japan
• Vitamin D and the Influenza Epidemic
• Influenza Antiviral DAS181-F03
• Prophylactic Efficacy of Relenza Against Influenza A and B
• Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
• Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation
• The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A
• The Chloroquine for Influenza Prevention Trial
• Auto-immunity in Lupus Patients After Influenza Vaccine
• Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
• Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
• Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza
• A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
• A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
• A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes
• A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza
• A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
• Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age
• Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza
• Collaborative H1N1 Adjuvant Treatment Pilot Trial
• A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
• A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain
• Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
• Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu
• Trial Comparing High Versus Standard Dose Oseltamivir in Severe Influenza Infection in ICU
• Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections
• Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days
• A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection
• Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir
• A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
• Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
• STIP: Statin Trial for Influenza Patients
• Rapid Evaluation of Seasonal Influenza Vaccine
• Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
• Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
• A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
• Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
• A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza
• Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects
• Sanofi H1N1 + TIV - Adults and Elderly
• Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
• Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study
• Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
• Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
• Influenza Resistance Information Study
• TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients
• VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactiva
• Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes
• Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit
• Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection
• Influenza Vaccination in the Emergency Department
• Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
• A Multinational Phase III Study of CS-8958 (MARVEL)
• Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir
• Zanamivir Versus Trivalent Split Virus Influenza Vaccine
• Vaccine for Prevention of Bird Flu
• Oseltamivir Randomised Controlled Efficacy Trial
• A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
• CS-8958 Single Inhaled Dose in Elderly
• Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer
• Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
• Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age
• Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza
• Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
• A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
• Single Dose Escalating Study of DAS181 in Adults
• Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
• Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
• Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
• Higher Dose Intradermal H5 Vaccine
• A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.
• Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
• A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants
• A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
• Safety Study of Avian Flu Vaccine
• Th1 Response to Influenza: Aging and Vaccine Efficacy
• Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza
• Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults
• Efficacy of Sambucol in the Treatment of Influenza
• Alternative Oseltamivir Dosing Strategies
• Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958
• Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.
• High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
• Safety and Dose Study of Peramivir for Influenza Treatment
• H5 Vaccine Alone or With Adjuvant in Healthy Adults
• Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines
• H5 Adult - Chiron Study of Bird Flu Vaccine
• Catechin Gargling for Influenza Infection
• Inactivated Influenza A/H5N1 Vaccine in the Elderly
• Influenza Vaccination and Oral Anticoagulant Therapy
• Influenza Vaccine in Lung Transplant Patients
• A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
• Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
• Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age